— Know what they know.
Not Investment Advice

MRVI NASDAQ

Maravai LifeSciences Holdings, Inc.
1W: +4.4% 1M: +21.4% 3M: +44.5% YTD: +31.8% 1Y: +86.7% 3Y: -66.5% 5Y: -88.2%
$4.40
-0.08 (-1.79%)
 
Weekly Expected Move ±13.9%
$3 $4 $4 $5 $5
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Buy · Power 68 · $1.2B mcap · 103M float · 2.04% daily turnover · Short 29% of daily vol

📊 Key Metrics

TTM
$205M
Revenue
-15.4% YoY
$-105M
Net Income
+35.7% YoY
$-52M
Free Cash Flow
-119.0% YoY
51.2%
Gross Margin
3.8%
Op. Margin
-5.7%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-38.9%
ROA-11.8%
ROIC114.2%

Valuation

P/E-6.2
P/B3.0
EV/EBITDA-2.3

Leverage

Debt/Equity0.17
Current Ratio6.60
Interest Cov.-6.1x

Quality Scores

Piotroski F3/9
Altman Z0.62
Beneish M-3.08

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms